When the Human Proteome Organization begins its meeting in Beijing on Oct. 25, pioneer proteomics scientist Ruedi Aebersold will not be there. Instead, Aebersold, a co-founder of the Institute for Systems Biology, will be heading to Zurich where he will create an interdisciplinary "faculty cluster" focused on systems biology at the Swiss Federal Institute of Technology Zurich (ETH Zurich). Aebersold will remain at ISB in Seattle full time into 2006 and will then transition to full-time professor of systems biology at ETH while retaining his faculty position with ISB.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.